Key facts for J2274
- Billing unit
- 10 MG
- Inj morphine pf epid ithc
- ASP payment limit
- $16.044
- October 2026; -15.2% vs July 2026
- Practitioner MUE
- 250
- MAI 3
- OPPS status
- SI N
- NCCI exposure
- no PTP pairs
- Coverage articles
- 1
- 7 states
TL;DR
HCPCS J2274 is the Level II code for Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg, billed per 10 MG. The Medicare Part B ASP payment limit for October 2026 is $16.044 per billing unit, down 15.2% from July 2026. The practitioner MUE allows up to 250 units per date of service (MAI 3), so a full 250-unit day is $4,011.00 at the current limit. Under OPPS it carries status indicator N. The 10 mg billing unit means doses are reported in multiples of ten milligrams, with any remainder rounded per contractor policy; mismatched units against the NDC quantity trigger MUE and NDC-unit edits. Site-specific administration routes in the descriptor tie the drug to a particular procedure code; the pairing is where NCCI column-1/column-2 edits and modifier decisions arise. Other HCPCS codes whose descriptor names morphine sulfate: J2272 (the Fresenius Kabi product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J2270). The ASP crosswalk maps 8 NDCs to it, sold as Morphine Sulfate, Duramorph, Infumorph 200 by Pfizer Inc, Hikma Pharmaceuticals USA Inc., Piramal Critical Care Inc. 1 Medicare coverage article lists the code across 7 states, including A56695.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for J2274 at $16.044 per 10 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $18.914 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $16.044 | 10 MG | 20% |
| July 2026 | $18.914 | 10 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 8 NDCs from 3 labelers to J2274. Report the NDC in the claim's drug segment and bill the number of J2274 units that equals the quantity administered divided by 10 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00409-3814-12 | Morphine Sulfate | Pfizer Inc | 10 × 5 | 3 |
| 00409-3815-12 | Morphine Sulfate | Pfizer Inc | 10 × 5 | 5 |
| 00641-6019-10 | Duramorph | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 10 |
| 00641-6020-10 | Duramorph | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 5 |
| 00641-6039-01 | Infumorph 200 | Hikma Pharmaceuticals USA Inc. | 20 × 1 | 20 |
| 00641-6040-01 | Infumorph 500 | Hikma Pharmaceuticals USA Inc. | 20 × 1 | 50 |
| 66794-0160-02 | Mitigo | Piramal Critical Care Inc | 20 × 1 | 20 |
| 66794-0162-02 | Mitigo | Piramal Critical Care Inc | 20 × 1 | 50 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for J2274. For practitioners the limit is 250 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 250 | 3 Date of Service Edit: Clinical | Clinical: Data |
| Facility outpatient hospital | 100 | 3 Date of Service Edit: Clinical | Clinical: Data |
| DME supplier | 0 | 3 Date of Service Edit: Clinical | CMS Policy |
MUE for J2274 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J2274 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J2274 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J2274 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
1 current Medicare Administrative Contractor article lists J2274 in their HCPCS tables, covering 7 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.
| Article | Title | Contractor(s) | States | Related LCD |
|---|---|---|---|---|
| A56695 | Billing and Coding: Implantable Infusion Pump | Palmetto GBA | AL GA NC SC TN VA WV | L33461 |
Diagnoses Medicare contractors cover for J2274
The article that lists J2274 ties its diagnosis groups to other procedure codes, so no covered ICD-10-CM list is attributed to J2274 itself; the diagnosis has to fit the group written for the procedure billed with the drug. See A56695.
Local coverage policies that list J2274
2 active Local Coverage Determinations list J2274 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- Implantable Infusion Pump, LCD L33461 · Palmetto GBA
- External Infusion Pumps (L33794) · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J2274 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), J2274 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.
Common denials for J2274 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for J2274
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J2274
What does HCPCS code J2274 describe?
J2274 is defined by CMS as "Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg". Each billing unit represents 10 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is J2274 a CPT code?
No. J2274 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as morphine sulfate; CPT codes are five-character codes maintained by the AMA. On a Part B claim J2274 reports the drug itself in 10 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for J2274 in October 2026?
The ASP-based payment limit is $16.044 per 10 MG, with 20% beneficiary coinsurance. The July 2026 limit was $18.914. Commercial payers use their own fee schedules.
How many units of J2274 can be billed per day?
The practitioner Medically Unlikely Edit is 250 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 100. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.
Which NDCs map to J2274?
The October 2026 ASP crosswalk lists 8 NDCs from 3 labelers: Morphine Sulfate (Pfizer Inc); Duramorph (Hikma Pharmaceuticals USA Inc.); Infumorph 200 (Hikma Pharmaceuticals USA Inc.); Infumorph 500 (Hikma Pharmaceuticals USA Inc.). For example NDC 00409-3814-12 (package size 10) equals 3 billing units of J2274.
Does J2274 have NCCI bundling edits?
No active practitioner PTP pairs list J2274 as a column-1 or column-2 code in the v323r0 release.
J2274 vs J2272: what is the difference?
Both are HCPCS Level II codes whose descriptor names morphine sulfate. What sets J2272 apart: the Fresenius Kabi product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J2270. J2274 is billed per 10 mg, limit $16.044, MUE 250; J2272 is billed per 10 mg, limit $9.406, MUE 9. Report the code whose descriptor matches the product and setting in the record.
Which Medicare coverage articles mention J2274?
1 current Billing and Coding Article in the Medicare Coverage Database lists J2274, covering 7 states: A56695 (Billing and Coding: Implantable Infusion Pump).
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.